Episode 256: ctDNA in Urothelial Studies

Matt Galsky, MD, talks about his new ctDNA study as well as how ctDNA may play a role in upcoming neoadjuvant trials.
Dr. Galsky is an oncologist and director of GU medical oncology at The Tisch Cancer Institute, Mount Sinai.